Telix jumps on cancer study update says CEO
MELBOURNE: Shares in cancer-fighter Telix Pharmaceuticals rose 3.8 per cent to $4.14 yesterday ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
